Therapeutic monoclonal antibodies
暂无分享，去创建一个
[1] D. Burton,et al. Covalent display of oligosaccharide arrays in microtiter plates. , 2004, Journal of the American Chemical Society.
[2] R. R. Robinson,et al. Escherichia coli secretion of an active chimeric antibody fragment. , 1988, Science.
[3] A. Poupon,et al. The immunoglobulin fold family: sequence analysis and 3D structure comparisons. , 1999, Protein engineering.
[4] R. Hansen,et al. Antibody pharmacokinetics and pharmacodynamics. , 2004, Journal of pharmaceutical sciences.
[5] S L Morrison,et al. Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[6] Wayne A Hendrickson,et al. Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[7] Dominique Bourgeois,et al. The crystal structure of a llama heavy chain variable domain , 1996, Nature Structural Biology.
[8] J. McMurry,et al. Immunogenicity Screening Using in Silico Methods: Correlation between T‐Cell Epitope Content and Clinical Immunogenicity of Monoclonal Antibodies , 2009 .
[9] Christoph Grundner,et al. Tyrosine Sulfation of Human Antibodies Contributes to Recognition of the CCR5 Binding Region of HIV-1 gp120 , 2003, Cell.
[10] A. Plückthun,et al. Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. , 1988, Science.
[11] A. Lesk,et al. Canonical structures for the hypervariable regions of immunoglobulins. , 1987, Journal of molecular biology.
[12] Ian A Wilson,et al. Structural basis of enhanced binding of extended and helically constrained peptide epitopes of the broadly neutralizing HIV-1 antibody 4E10. , 2007, Journal of molecular biology.
[13] K. Roux,et al. Flexibility of human IgG subclasses. , 1997, Journal of immunology.
[14] T. T. Wu,et al. AN ANALYSIS OF THE SEQUENCES OF THE VARIABLE REGIONS OF BENCE JONES PROTEINS AND MYELOMA LIGHT CHAINS AND THEIR IMPLICATIONS FOR ANTIBODY COMPLEMENTARITY , 1970, The Journal of experimental medicine.
[15] C. Milstein,et al. Conformational isomerism and the diversity of antibodies. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[16] P. Lu,et al. Therapeutic Antibodies in Clinical Use and Leading Clinical Candidates , 2009 .
[17] H. Katinger,et al. The Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2G12 Recognizes a Cluster of α1→2 Mannose Residues on the Outer Face of gp120 , 2002, Journal of Virology.
[18] D. Fremont,et al. Structural aspects of antibodies and antibody-antigen complexes. , 2007, Ciba Foundation symposium.
[19] I. Wilson,et al. Three-dimensional structure of an anti-steroid Fab' and progesterone-Fab' complex. , 1993, Journal of molecular biology.
[20] Renate Kunert,et al. Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41. , 2005, Immunity.
[21] Alexander McPherson,et al. The three-dimensional structure of an intact monoclonal antibody for canine lymphoma , 1992, Nature.
[22] D. Burton,et al. Crystal structure of the broadly cross-reactive HIV-1-neutralizing Fab X5 and fine mapping of its epitope. , 2004, Biochemistry.
[23] Ian A. Wilson,et al. Molecular basis of crossreactivity and the limits of antibodyantigen complementarity , 1993, Nature.
[24] Oleg V. Koliasnikov,et al. Antibody Cdr H3 Modeling Rules: Extension for the Case of Absence of Arg H94 and Asp H101 , 2006, J. Bioinform. Comput. Biol..
[25] H. Katinger,et al. Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[26] R L Stanfield,et al. Antibody-antigen interactions: new structures and new conformational changes. , 1994, Current opinion in structural biology.
[27] G. Cohen,et al. The three-dimensional structure of a phosphorylcholine-binding mouse immunoglobulin Fab and the nature of the antigen binding site. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[28] D R Burton,et al. Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda. , 1989, Science.
[29] Andrew C. R. Martin,et al. Analysis of the antigen combining site: correlations between length and sequence composition of the hypervariable loops and the nature of the antigen. , 2003, Journal of molecular biology.
[30] Bette Korber,et al. Structure of a V3-Containing HIV-1 gp120 Core , 2005, Science.
[31] W Wang,et al. Monoclonal Antibody Pharmacokinetics and Pharmacodynamics , 2008, Clinical pharmacology and therapeutics.
[32] Garrett M. Morris,et al. Crystal Structure of a Neutralizing Human IgG Against HIV-1: A Template for Vaccine Design , 2001, Science.
[33] A. Lesk,et al. Standard conformations for the canonical structures of immunoglobulins. , 1997, Journal of molecular biology.
[34] Ping Zhu,et al. Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition , 2003, Science.
[35] I. Wilson,et al. Antigen-induced conformational changes in antibodies: a problem for structural prediction and design. , 1994, Trends in biotechnology.